Notice Number: NOT-AA-09-001

Key Dates
Release Date: March 12, 2009

Issued by
National Institute on Alcohol Abuse and Alcoholism (NIAAA), (http://www.niaaa.nih.gov/)

Purpose

This Notice announces the participation of the NATIONAL INSTITUTE OF ALCOHOL ABUSE AND ALCOHOLISM (NIAAA) in PA-09-106 (R01) and PA-09-107(R21) entitled Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates. .

The following Institute continues to participate in PA-09-106 and PA-09-107:
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov/)

All other aspects of these Program Announcements remain unchanged.

Inquiries

Inquiries and discussion of plans for responding to this Notice are strongly encouraged.

Program Contact:

Dale Hereld, M.D., Ph.D.
Division of Metabolism and Health Effects
National Institute on Alcohol Abuse and Alcoholism
5635 Fishers Lane, Room 2027, MSC 9304
Bethesda, MD 20892-9304
Telephone: (301) 443-0912
FAX: (301) 594-0673
Email: [email protected]

Grants Management Contact:

Judy Fox
Grants Management Branch
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health, DHHS
5635 Fishers Lane MSC 9304 Room 3023
Bethesda, MD 20892-9304
[For express mail use: Rockville, MD 20852-1705]
Telephone: 301-443-4704
FAX: 301-443-3891
Email: [email protected]